Craig-Hallum analyst Matt Hewitt raised the firm’s price target on Champions Oncology (CSBR) to $12 from $8 and keeps a Buy rating on the ...
Q3 2025 Earnings Call Transcript March 11, 2025 Champions Oncology, Inc. beats earnings expectations. Reported EPS is $0.3181 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback